• Users Online: 454
  • Print this page
  • Email this page

Table of Contents
Year : 2020  |  Volume : 31  |  Issue : 3  |  Page : 143-144

CME Test

Date of Web Publication26-Jun-2020

Correspondence Address:
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/1879-5226.287972

Get Permissions

How to cite this article:
. CME Test. Urol Sci 2020;31:143-4

How to cite this URL:
. CME Test. Urol Sci [serial online] 2020 [cited 2021 Apr 18];31:143-4. Available from: https://www.e-urol-sci.com/text.asp?2020/31/3/143/287972

  Cme Test Top

Please read this issue of Urological Science and return the postage-paid reply slip with your answers by August, 2020. A score of 80% or better will earn two CME credits. Questions/answers:

1. What statement considering the predictor of undiscovered urolithiasis in patients with acute urinary tract infection (UTI) symptoms is correct?

  1. Both red blood cells (RBCs) and white blood cells (WBCs) were not predictors of urolithiasis.
  2. In patients presenting with acute UTI symptoms, a lower RBC median and a higher WBC median in urinalysisare correlated with a higher probability to have urolithiasis.
  3. In patients with flank pain or hydronephrosis, a urine WBC median of <7.75 per HPF has a sensitivity of 73% for predicting urolithiasis on a CT scan
  4. In patients with flank pain or hydronephrosis, a urine WBC median of >7.75 per HPF has a sensitivity of 73% for predicting urolithiasis on a CT scan
  5. All statements are incorrect.

Urol Sci 2020:31(3):115-121.

2. What statement considering the medical treatment for overactive bladder (OAB) is incorrect?

  1. Newer antimuscarinic drugs focus on more selective muscarinic receptors with less side effects.
  2. ß3AR agonists have little effects on voiding contraction caused by muscarinic receptor, and it can increase bladder capacity without change in residual volume.
  3. In many studies, the combination therapy with antimuscarinic agent and ß3AR agonist demonstrated increased efficacy and acceptable tolerability.
  4. Several trials had investigated the efficacy and safety of PDE5I and pregabalin for OAB treatment, but further study is needed.
  5. All statements are incorrect.

Urol Sci 2020:31(3):91-98.

3. Compared to theα- blocker monotherapy for BPH-LUTS, what statement considering the combination therapy withα- blocker and Phosphodiesterase 5 inhibitors (PDE5is) is incorrect?

  1. Better IPSS storage subscore.
  2. Better Qmax.
  3. Better IPSS QOL score.
  4. Decrease the risk of adverse events.
  5. Better erectile function.

Urol Sci 2020:31(3):99-107.

4. According to the study by ChenChe Lee et al., what statement about the Impact of Pseudoephedrine and Antihistamine on Lower Urinary Tract Symptoms (LUTS) is correct?

  1. Both pseudoephedrine and antihistamine have major effects on lower urinary tract function in the general male population.
  2. Pseudoephedrine worsened IPSS total score in elderly men.
  3. Antihistamines worsened IPSS storage subscore in younger men.
  4. Antihistamines worsened IPSS voiding subscore in elderly men.
  5. In selfunaware voiding dysfunction male with IPSS total score >7, Antihistamines may cause more post-void residual urine amount.

Urol Sci 2020:31(3):108-113.

5. What statement considering the clinical profile of renal trauma in India is incorrect?

  1. Rib fracture was the most common associated injury.
  2. Most patient had unilateral renal injury, not bilateral renal injury.
  3. Length of hospital stay was increasing with the severity of renal injury from Grade I to Grade V.
  4. Grade of renal injury and type of treatment significantly affected the variations in the length of hospital stay.
  5. All statement are correct.

Urol Sci 2020:31(3):131-135.

Volume 31 Issue 2


1. (E) 2. (C) 3. (C) 4. (C) 5. (C)


    Similar in PUBMED
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this article
Cme Test

 Article Access Statistics
    PDF Downloaded37    
    Comments [Add]    

Recommend this journal